Equity · Healthcare
LH
NYSELabcorp Holdings (LH)
The line runs 323 USD on 12 August through 371.99 USD on 9 November, on a scale from 300 to 380. Days the market did not trade hold the previous close, flat.
- Market cap
- 30.2B USD
- P/E (TTM)
- 30.5
- Revenue, year to Dec 2025
- 14.0B USD
- EPS, diluted, year to Dec 2025
- 10.46 USD
- 52-week range
- 246 USD – 371.99 USD
- Avg volume
- 51.3K
- Mentions, 30 days
- 1
as of Nov 9, 2026
Have Labcorp Holdings (LH) insiders bought or sold shares recently?
In the 90 days to 11 Nov 2026, Labcorp Holdings insiders reported 3 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 7 Feb 2026, show no open-market purchase.
Form 4, 90 days to 11 Nov 2026, newest reported trade 3 Nov 2026
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 03 Nov 2026 | Vaughn Bryan TEVP and President, Diagnostics | Sell | 306 | 108K USD |
| 30 Oct 2026 | Parham Richelle PDirector | Sell | 1,078 | 389K USD |
| 17 Aug 2026 | ANDERSON KERRII BDirector | Sell | 3,000 | 954K USD |
| Sold | 3 open-market sales | 4,384 | $1.45M |
4 other filings in the window: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 02 Nov 2026 | Vaughn Bryan TEVP and President, Diagnostics | Tax withheld | 194 | 69K USD |
| 02 Nov 2026 | Oyegunwa AkinboladeEVP, CIO & CTO | Tax withheld | 118 | 42K USD |
| 01 Nov 2026 | Vaughn Bryan TEVP and President, Diagnostics | Option exercise | 500 | |
| 01 Nov 2026 | Oyegunwa AkinboladeEVP, CIO & CTO | Option exercise | 370 |
Which funds hold Labcorp Holdings (LH)?
1 of the 45 institutional funds we track reported a Labcorp Holdings position for the quarter ended 30 Sep 2026 — a combined 480K USD; the latest of those filings landed 06 Nov 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Fisher Asset Management | Held (±25%) | 1,556 | 480K USD | +19.6% |
Have members of Congress traded Labcorp Holdings (LH)?
The most recent congressional trade disclosed in Labcorp Holdings is a sale by April McClain Delaney (house, MD), dated 25 Aug 2026.
STOCK Act disclosures
| Traded | Member | Type | Amount | Filed after |
|---|---|---|---|---|
| 25 Aug 2026 | April McClain Delaneyhouse · Democrat–MD | Sale | 100K USD–250K USD | 15 days |
| 06 Aug 2026 | April McClain Delaneyhouse · Democrat–MD | Sale | 1K USD–15K USD | 34 days |
| 04 Feb 2026 | April McClain Delaneyhouse · Democrat–MD | Purchase | 1K USD–15K USD | 34 days |
| 28 Jan 2026 | April McClain Delaneyhouse · Democrat–MD | Purchase | 1K USD–15K USD | 5 days |
| 17 Nov 2025 | April McClain Delaneyhouse · Democrat–MD | Purchase | 1K USD–15K USD | 21 days |
| 31 Oct 2025 | April McClain Delaneyhouse · Democrat–MD | Purchase | 1K USD–15K USD | 4 days |
| 29 Oct 2025 | April McClain Delaneyhouse · Democrat–MD | Purchase | 1K USD–15K USD | 6 days |
| 15 May 2025 | Robert P. Bresnahan, Jr.house · Republican–PA | Purchase | 1K USD–15K USD | 16 days |
What has been filed or recorded for Labcorp Holdings (LH)?
The filings we hold for Labcorp Holdings, newest first: 4 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 14 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 14 Oct 2026 | Fails to deliver | Shares failed to deliver | 36 shares | 11K USD notional · <0.001% of shares out |
| 06 Oct 2026 | Fails to deliver | Shares failed to deliver | 45 shares | 14K USD notional · <0.001% of shares out |
| 05 Oct 2026 | Fails to deliver | Shares failed to deliver | 27 shares | 8K USD notional · <0.001% of shares out |
| 02 Oct 2026 | Fails to deliver | Shares failed to deliver | 254 shares | 77K USD notional · <0.001% of shares out |
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS 3.22 USD | Revenue $3.81B |
| 30 Sep 2026 | Financials | Total assets | 18.9B USD | at period end |
| 30 Sep 2026 | Financials | Total equity | 8.8B USD | at period end |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS 3.64 USD | Revenue $3.73B |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS 3.35 USD | Revenue $3.54B |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS 10.46 USD | Revenue $13.95B |
| 31 Dec 2025 | Financials | Revenue | 14.0B USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | 876.5M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | 10.46 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS 3.12 USD | Revenue $3.56B |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS 2.84 USD | Revenue $3.53B |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS 2.52 USD | Revenue $3.35B |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS 8.84 USD | Revenue $13.01B |
What is Reddit saying about Labcorp Holdings (LH)?
Reddit mentioned LH 1 times in the 30 days to 10 November 2026, in 1 of the communities we track. All of them were scored for sentiment: 100% read bullish, 0% bearish and 0% neither. Reddit data updated 10 November 2026.
30-day window, Method
How do Reddit mentions of Labcorp Holdings (LH) compare with its price?
Share ↗
Which subreddits are talking about Labcorp Holdings (LH)?
30 days
| Community | Share | Mentions | Net sentiment |
|---|---|---|---|
| r/wallstreetbets | 100% | 1 | +0.16 |
What do people ask about Labcorp Holdings (LH)?
What did Labcorp Holdings shares close at?371.99
Labcorp Holdings closed at 371.99 USD on 9 Nov 2026, up 1.46% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Labcorp Holdings’ market cap?30.2B
Labcorp Holdings is worth 30.2B USD by market value as of 9 Nov 2026, which is the share price times the shares on issue from its SEC filings.
What is Labcorp Holdings’ P/E ratio?30.5
Labcorp Holdings has a price-to-earnings ratio of 30.5, as of 9 Nov 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.
What is Labcorp Holdings’ revenue?14.0B
Labcorp Holdings reported revenue of 14.0B USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Labcorp Holdings insiders bought or sold shares recently?3 sales
In the 90 days to 11 Nov 2026, Labcorp Holdings insiders reported 3 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 7 Feb 2026, show no open-market purchase. A further 4 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders
Which funds own Labcorp Holdings?1 of 45
1 of the 45 funds we track reported a Labcorp Holdings position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported position was Fisher Asset Management. See Funds
Have members of Congress traded Labcorp Holdings?20 trades
Yes. 20 trades in Labcorp Holdings appear in the congressional disclosures we hold; the latest is a sale by April McClain Delaney (House, MD) dated 25 Aug 2026, filed 9 Sep 2026. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress
When did Labcorp Holdings last report earnings?3.22
Labcorp Holdings last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of 3.22 USD; no next date is announced in SEC filings yet. See Filings
What is Reddit saying about Labcorp Holdings?0 mentions
Labcorp Holdings was mentioned 0 times in the last 7 days across the finance subreddits we track, and 1 times over the trailing 30 days. Of the 1 mentions scored for sentiment, 100% read bullish and 0% bearish. That is a social signal, not investment advice. See Reddit
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), most closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- Wikimedia CommonsPortraits via Wikimedia Commons. Robert P. Bresnahan, Jr.: House Creative Services, Public domain; April McClain Delaney: Ike Hayman, House Creative Services, Public domain.
- House disclosuresU.S. House of Representatives financial disclosures
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings